Pharmaceutical Technology51m
RFK Jr shifts stance on MMR vaccine amid measles deaths
RFK Jr supported the MMR vaccine’s efficacy in preventing measles, but also shared unproven treatment strategies.
Pharmaceutical Technology1h
Rhythm seeks market expansion for Imcivree following Phase III victory
Rhythm's Imcivree has shown benefit in a Phase III trial in patients with acquired hypothalamic obesity, leading to 19.8% ...
Pharmaceutical Technology1h
AD/PD 2025: First real-world data report for Leqembi focuses on operational challenges
Following the launch of the first disease-modifying therapies for Alzheimer’s disease, a key theme at the AD/PD 2025 ...
Pharmaceutical Technology5h
China’s NMPA authorises Santen’s glaucoma treatment application
China’s NMPA has granted approval for the marketing authorisation application of Santen Pharmaceutical's Tapcom.
Pharmaceutical Technology7h
Obesity drugs won’t be covered by Medicare under 2026 CMS policy
The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...
Pharmaceutical Technology8h
EC approves AstraZeneca’s Imfinzi combo for NSCLC
The European Commission (EC) has granted approval for AstraZeneca's Imfinzi plus chemotherapy for treating resectable NSCLC ...
Pharmaceutical Technology10h
ABL Bio and GSK link on neurodegenerative conditions
ABL Bio has announced a global licensing agreement with GSK, allowing the latter to develop medicines for neurodegenerative ...